On this page
TNNT1
troponin T1, slow skeletal type
TNNT1 is located on the long (q) arm of chromosome 19, at band 19q13.42. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 19 in the library →Available at Jeen Health
Clinical tests that include this
Overview
TNNT1 encodes troponin T1, one of three proteins forming the troponin complex in slow skeletal muscle. This complex acts as a molecular switch controlling when muscle fibres contract in response to calcium signals. Slow-twitch muscle fibres, which rely on TNNT1, are specialised for sustained, controlled movements rather than rapid bursts of activity.
Pathogenic variants in TNNT1 follow an autosomal recessive inheritance pattern, meaning two altered copies are required to cause disease. The gene is clinically relevant in the context of congenital muscle disorders that manifest from birth or early infancy, often characterised by muscle weakness and structural abnormalities visible under microscopy.
What the gene does
The TNNT1 protein functions as the tropomyosin-binding component of the troponin regulatory complex in slow skeletal muscle fibres. When calcium ions enter muscle cells during contraction signals, they bind to troponin C within the complex. This binding triggers a conformational change transmitted through troponin T1, which shifts tropomyosin molecules along the thin filament. The tropomyosin movement exposes binding sites on actin, allowing myosin motor proteins to attach and generate the force needed for muscle contraction.
Troponin T1 is specifically expressed in type I (slow-twitch) muscle fibres, which predominate in postural muscles and are adapted for endurance activities requiring sustained, fatigue-resistant contractions. The protein anchors the troponin complex to tropomyosin while also communicating regulatory signals from calcium-binding events to the contractile machinery. Disruption of TNNT1 function impairs the precision of calcium-dependent regulation, leading to inefficient or uncoordinated muscle contractions that manifest as weakness and structural muscle pathology.
Video: Genetics 101
Chromosome location
TNNT1 is located on the long arm of chromosome 19 at position 19q13.42, a gene-dense region near the telomere. The chromosomal band 19q13 contains numerous genes involved in muscle and metabolic function. The precise genomic architecture of TNNT1, including exon number and transcript variants, contributes to the tissue-specific expression pattern observed in slow skeletal muscle.
Protein structure
The TNNT1 protein comprises 278 amino acids. Structural analysis reveals two disordered regions spanning amino acids 1-63 and 105-153. These intrinsically disordered segments lack fixed three-dimensional structure under physiological conditions but are functionally important for protein flexibility and binding interactions. The disordered nature of these regions allows TNNT1 to undergo conformational changes during the calcium-signalling cycle, facilitating communication between troponin C and the tropomyosin-actin interface. The N-terminal disordered region participates in regulatory interactions, while the central disordered segment contributes to the protein's ability to transmit structural signals across the troponin complex.
Key variants
Pathogenic variants in TNNT1 are predominantly loss-of-function changes that reduce or eliminate protein activity. Missense variants altering critical residues involved in tropomyosin binding or calcium-signal transmission account for some cases, whilst nonsense and frameshift variants that introduce premature termination codons are also reported. The variant spectrum reflects the autosomal recessive inheritance pattern, with affected individuals typically carrying two pathogenic alleles. Specific founder mutations have been identified in certain populations, though the overall allele frequency remains low in the general population.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
Pathogenic variants in TNNT1 cause nemaline myopathy, a congenital muscle disorder characterised by muscle weakness, hypotonia, and the presence of rod-shaped (nemaline) structures within muscle fibres visible on biopsy. Nemaline myopathy presents with a range of severity, from severe congenital forms with respiratory compromise to milder childhood-onset disease. The Amish nemaline myopathy subtype, observed in specific populations, represents a distinct clinical presentation associated with recurrent TNNT1 variants. Muscle weakness typically affects proximal and axial muscles, and some individuals experience feeding difficulties or delayed motor milestones in infancy.
No disease links recorded for this gene in our reference set.
Inheritance pattern
Conditions caused by pathogenic TNNT1 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
TNNT1 appears on multiple NHS Genomic Medicine Service gene panels with green (high evidence) classification. The gene is included in the Congenital myopathy panel (R81), reflecting its established role in inherited muscle disease. TNNT1 is also listed on the Arthrogryposis panel (R83), recognising its association with congenital joint contractures that may accompany severe muscle weakness. Additionally, the gene features on the Fetal anomalies panel (R21), relevant for prenatal cases where severe muscle involvement is detected through imaging or reduced foetal movement.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What inheritance pattern does TNNT1 follow?
TNNT1-related conditions follow an autosomal recessive inheritance pattern. An individual must inherit two pathogenic variants, one from each parent, to develop disease. Parents who each carry one variant are typically unaffected carriers.
Why is TNNT1 specifically associated with slow muscle fibres?
TNNT1 encodes a troponin isoform expressed exclusively in type I (slow-twitch) muscle fibres, which are specialised for sustained contractions and postural control. Fast-twitch fibres use different troponin isoforms encoded by separate genes, explaining the specific muscle involvement pattern in TNNT1-related myopathy.
How is TNNT1-related myopathy diagnosed?
Diagnosis typically combines clinical assessment of muscle weakness, muscle biopsy showing characteristic nemaline rods, and genetic testing to identify pathogenic TNNT1 variants. Elevated serum creatine kinase and electromyography findings may support the diagnosis, though genetic confirmation is definitive.